{"id":"https://openalex.org/W2995354875","doi":"https://doi.org/10.1038/s41598-019-55096-9","title":"Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models","display_name":"Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models","alternate_titles":[],"publication_year":2019,"publication_date":"2019-12-10","ids":{"openalex":"https://openalex.org/W2995354875","doi":"https://doi.org/10.1038/s41598-019-55096-9","mag":"2995354875","pmid":"https://pubmed.ncbi.nlm.nih.gov/31822716","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6904563"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-019-55096-9","doi":"https://doi.org/10.1038/s41598-019-55096-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-019-55096-9","pdf_url":"https://www.nature.com/articles/s41598-019-55096-9.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2995354875"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-019-55096-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013140743","display_name":"Simon P. Langdon","orcid":"https://orcid.org/0000-0002-7200-9237","observed_orcids":["https://orcid.org/0000-0002-7200-9237"]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I4210158898","display_name":"Institute of Genetics and Cancer","ror":"https://ror.org/05hygey35","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210158898","https://openalex.org/I90344618","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Simon P. Langdon","raw_affiliation_strings":["Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom. simon.langdon@ed.ac.uk","Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom. simon.langdon@ed.ac.uk","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I4210158898","https://openalex.org/I98677209"]},{"raw_affiliation_string":"Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091787661","display_name":"Charlene Kay","orcid":"https://orcid.org/0000-0002-7454-9528","observed_orcids":["https://orcid.org/0000-0002-7454-9528"]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlene Kay","raw_affiliation_strings":["Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010468035","display_name":"In Hwa Um","orcid":"https://orcid.org/0000-0001-9999-4292","observed_orcids":["https://orcid.org/0000-0001-9999-4292"]},"institutions":[{"id":"https://openalex.org/I16835326","display_name":"University of St Andrews","ror":"https://ror.org/02wn5qz54","country_code":"GB","type":"education","lineage":["https://openalex.org/I16835326"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"In Hwa Um","raw_affiliation_strings":["Pathology, School of Medicine, University of St. Andrews, North Haugh, St. Andrews, Fife, KY16 9TF, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, School of Medicine, University of St. Andrews, North Haugh, St. Andrews, Fife, KY16 9TF, United Kingdom","institution_ids":["https://openalex.org/I16835326"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Dodds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Dodds","raw_affiliation_strings":["Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Edinburgh Centre and Edinburgh Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022043525","display_name":"Morwenna Muir","orcid":"https://orcid.org/0000-0001-5835-3886","observed_orcids":["https://orcid.org/0000-0001-5835-3886"]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I4210158898","display_name":"Institute of Genetics and Cancer","ror":"https://ror.org/05hygey35","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210158898","https://openalex.org/I90344618","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Morwenna Muir","raw_affiliation_strings":["Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I4210158898","https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111945602","display_name":"Grant C. Sellar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Grant Sellar","raw_affiliation_strings":["Wyeth Translational Medicine Research Consortium, Sir James Black Centre, Dow Street, Dundee, DD1 5EH, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Translational Medicine Research Consortium, Sir James Black Centre, Dow Street, Dundee, DD1 5EH, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110212693","display_name":"Julie L.C. Kan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julie Kan","raw_affiliation_strings":["Pfizer Translational Pharmacology, Oncology, San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Translational Pharmacology, Oncology, San Diego, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009351129","display_name":"Charlie Gourley","orcid":"https://orcid.org/0000-0002-2377-7221","observed_orcids":["https://orcid.org/0000-0002-2377-7221"]},"institutions":[{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I4210158898","display_name":"Institute of Genetics and Cancer","ror":"https://ror.org/05hygey35","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210158898","https://openalex.org/I90344618","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlie Gourley","raw_affiliation_strings":["Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom","institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I4210158898","https://openalex.org/I98677209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064922783","display_name":"David James Harrison","orcid":"https://orcid.org/0000-0001-9041-9988","observed_orcids":["https://orcid.org/0000-0001-9041-9988"]},"institutions":[{"id":"https://openalex.org/I16835326","display_name":"University of St Andrews","ror":"https://ror.org/02wn5qz54","country_code":"GB","type":"education","lineage":["https://openalex.org/I16835326"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Harrison","raw_affiliation_strings":["Pathology, School of Medicine, University of St. Andrews, North Haugh, St. Andrews, Fife, KY16 9TF, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-9041-9988","affiliations":[{"raw_affiliation_string":"Pathology, School of Medicine, University of St. Andrews, North Haugh, St. Andrews, Fife, KY16 9TF, United Kingdom","institution_ids":["https://openalex.org/I16835326"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5013140743"],"corresponding_institution_ids":["https://openalex.org/I2802581871","https://openalex.org/I4210158898","https://openalex.org/I98677209"],"apc_list":{"value":1790,"currency":"USD","value_usd":1790},"apc_paid":{"value":1790,"currency":"USD","value_usd":1790},"fwci":0.912,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.69527498,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"9","issue":"1","first_page":"18742","last_page":"18742"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gedatolisib","display_name":"gedatolisib","score":0.9390000104904175},{"id":"https://openalex.org/keywords/pf-04691502","display_name":"PF-04691502","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.875},{"id":"https://openalex.org/keywords/phospho-s6","display_name":"phospho-S6","score":0.828000009059906},{"id":"https://openalex.org/keywords/phospho-akt","display_name":"phospho-Akt","score":0.9399999976158142},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8019999861717224},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.7319999933242798},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8513076305389404},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6292147636413574},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5996596217155457},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5805538892745972},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.5479637384414673},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5338885188102722},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4289803206920624},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.42725998163223267},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4177056550979614},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3241633176803589},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31258493661880493},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18980705738067627},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010053","descriptor_name":"Ovary","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1038/s41598-019-55096-9","doi":"https://doi.org/10.1038/s41598-019-55096-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-019-55096-9","pdf_url":"https://www.nature.com/articles/s41598-019-55096-9.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6904563","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6904563/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:31822716","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31822716","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"},{"id":"pmh:oai:pure.ed.ac.uk:openaire/31c28b1b-ace2-4cf2-b9f1-a148858ebe95","doi":null,"is_oa":true,"landing_page_url":"https://www.research.ed.ac.uk/files/124606947/Evaluation_of_the_dual_mTOR_P13K.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400321","display_name":"Edinburgh Research Explorer (University of Edinburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98677209","host_organization_name":"University of Edinburgh","host_organization_lineage":["https://openalex.org/I98677209"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Langdon, S P, Kay, C, Um, I H, Dodds, M, Muir, M, Sellar, G, Kan, J, Gourley, C & Harrison, D J 2019, 'Evaluation of the dual mTOR / PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models', Scientific Reports. https://doi.org/10.1038/s41598-019-55096-9","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:14a7721637844b5b88e9eecefff2d20f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/14a7721637844b5b88e9eecefff2d20f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)","raw_type":"article"},{"id":"pmh:oai:research-repository.st-andrews.ac.uk:10023/19120","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10023/19120","pdf_url":null,"source":{"id":"https://openalex.org/S4306400230","display_name":"St Andrews Research Repository (St Andrews Research Repository)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I16835326","host_organization_name":"University of St Andrews","host_organization_lineage":["https://openalex.org/I16835326"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"}],"best_oa_location":{"id":"doi:10.1038/s41598-019-55096-9","doi":"https://doi.org/10.1038/s41598-019-55096-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-019-55096-9","pdf_url":"https://www.nature.com/articles/s41598-019-55096-9.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3486700330","display_name":null,"funder_award_id":"SRDG HR07005","funder_id":"https://openalex.org/F4320320064","funder_display_name":"Scottish Funding Council"},{"id":"https://openalex.org/G3898101187","display_name":null,"funder_award_id":"HR07005","funder_id":"https://openalex.org/F4320320064","funder_display_name":"Scottish Funding Council"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320320064","display_name":"Scottish Funding Council","ror":"https://ror.org/056bwcz71"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2995354875.pdf","grobid_xml":"https://content.openalex.org/works/W2995354875.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W136092066","https://openalex.org/W1863928641","https://openalex.org/W1968109047","https://openalex.org/W1974208182","https://openalex.org/W1981989535","https://openalex.org/W1993195370","https://openalex.org/W1997640760","https://openalex.org/W2010568575","https://openalex.org/W2014096417","https://openalex.org/W2021012077","https://openalex.org/W2023708006","https://openalex.org/W2040715170","https://openalex.org/W2042856538","https://openalex.org/W2048109276","https://openalex.org/W2050910224","https://openalex.org/W2062441961","https://openalex.org/W2069404284","https://openalex.org/W2086281394","https://openalex.org/W2090968329","https://openalex.org/W2119855881","https://openalex.org/W2126783165","https://openalex.org/W2141204494","https://openalex.org/W2141307152","https://openalex.org/W2157983986","https://openalex.org/W2216554257","https://openalex.org/W2295965007","https://openalex.org/W2466225656","https://openalex.org/W2531232117","https://openalex.org/W2588723373","https://openalex.org/W2595509024","https://openalex.org/W2739639286","https://openalex.org/W2765084883","https://openalex.org/W4238567307"],"related_works":["https://openalex.org/W3021280920","https://openalex.org/W4394738998","https://openalex.org/W2119855881","https://openalex.org/W2279964776","https://openalex.org/W1984777958","https://openalex.org/W2531232117","https://openalex.org/W2040715170","https://openalex.org/W2045689371","https://openalex.org/W2810892831","https://openalex.org/W2324852261"],"abstract_inverted_index":{"This":[0],"study":[1],"investigated":[2],"the":[3,44,67,101,105],"antitumour":[4,32],"effects":[5],"of":[6,18,50,63,70,95,118,126,167],"two":[7,86],"dual":[8,28],"mTOR/PI3K":[9,29,176],"inhibitors,":[10],"gedatolisib":[11],"(WYE-129587/PKI-587/PF-05212384)":[12],"and":[13,47,146,194],"PF-04691502":[14],"against":[15,34],"a":[16,93,124],"panel":[17],"six":[19],"human":[20],"patient":[21],"derived":[22],"ovarian":[23,186],"cancer":[24,187],"xenograft":[25,87,107,188],"models.":[26],"Both":[27,159],"inhibitors":[30],"demonstrated":[31],"activity":[33],"all":[35],"xenografts":[36],"tested.":[37],"The":[38],"compounds":[39],"produced":[40,161],"tumour":[41,64,73,141,182],"stasis":[42,184],"during":[43,79,190],"treatment":[45,71,102,145,150,193],"period":[46,103],"upon":[48],"cessation":[49,117,151],"treatment,":[51],"tumours":[52],"re-grew.":[53],"In":[54],"several":[55],"models,":[56],"there":[57],"was":[58,77,98,128,152],"an":[59],"initial":[60],"rapid":[61],"reduction":[62,143],"volume":[65,142],"over":[66,100],"first":[68],"week":[69],"before":[72],"stasis.":[74],"No":[75],"toxicity":[76],"observed":[78],"treatment.":[80,119],"Biomarker":[81],"studies":[82],"were":[83],"conducted":[84],"in":[85,104,185],"models;":[88],"phospho-S6":[89,138],"(Ser235/236)":[90],"expression":[91,109,122,157],"(as":[92,123],"readout":[94,125],"mTOR":[96],"activity)":[97],"reduced":[99],"responding":[106],"but":[108,133,163],"increased":[110],"to":[111],"control":[112],"(no":[113],"treatment)":[114],"levels":[115],"on":[116,144],"Phospho-AKT":[120],"(Ser473)":[121],"PI3K)":[127],"inhibited":[129],"by":[130],"both":[131],"drugs":[132,160],"less":[134],"markedly":[135],"so":[136],"than":[137],"expression.":[139],"Initial":[140],"regrowth":[147],"rate":[148],"after":[149],"associated":[153,197],"with":[154,198],"phospho-S6/total":[155],"S6":[156],"ratio.":[158],"apoptosis":[162],"minimally":[164],"influenced":[165],"markers":[166],"proliferation":[168],"(Ki67,":[169],"phospho-histone":[170],"H3).":[171],"These":[172],"results":[173],"indicate":[174],"that":[175],"inhibition":[177],"can":[178],"produce":[179],"broad":[180],"spectrum":[181],"growth":[183],"models":[189],"continuous":[191],"chronic":[192],"this":[195],"is":[196],"apoptosis.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2995354875","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-12-26T00:00:00"}
